<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-126542</identifier>
<setSpec>1135-5727</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Social and economic impact of chickem pox vaccine at 15 months of age. Castile and Leon, Spain, 2004</dc:title>
<dc:description xml:lang="en">Background: Chicken pox is a mainly childhood contagious disease caused by the Varicella Zoster Virus which gives rise to major healthcare and social costs. In 2005, Castile and Leon added chicken pox vaccine injections to its childhood vaccination schedule for eleven year-olds subject to coming down with this disease. This strategy does not modify the major mobility generated thereby at younger ages. This study is aimed at evaluating the profitability of systematic vaccination for chicken pox in infants 15 months of age in Castile and Leon. Methods: An economic cost-benefit evaluation has been set out by jeans of a decision-making tree. A fictitious cohort of 100,000 children in Castile and Leon having reached 15 months of age in 2004 is studied, to whom the chicken pox vaccine would be administered in conjunction with the mumps, measles, rubella vaccines. This study is approached from the social standpoint. The time horizon selected was that of up until the study cohort was to reach 15 years of age, applying a 3% discount rate. A sensitivity analysis was made for evaluating the uncertainty of some variables... Results: The cost-benefit ratio of adding this vaccine to the childhood vaccination schedule amounts to 1.23. Conclusions: From the social standpoint, administering chicken pox vaccine in conjunction with the mumps, measles, rubella vaccines show itself to be profitable. The profitability is modified both if a second dose of vaccine is added as well as if only the direct healthcare costs are analyzed (AU)</dc:description>
<dc:creator>Gil Costa, M</dc:creator>
<dc:creator>Ortiz de Lejarazu, R</dc:creator>
<dc:creator>Eiros Bouza, J</dc:creator>
<dc:creator>Castrodeza Sanz, J. J</dc:creator>
<dc:creator>Pérez-Rubio, A</dc:creator>
<dc:creator>Luquero Alcalde, f. J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento: La varicela es una enfermedad infecciosa fundamentalmente infantil producida por el virus Herpes Varicela Zoster que produce importantes costes sanitarios y sociales. En 2005 Castilla y León introdujo en su calendario de vacunación infantil la vacuna de la varicela a los niños de once años susceptibles de padecerla. Dicha estrategia no modifica la importante morbilidad que genera en edades inferiores. El objetivo de este trabajo es valorar la rentabilidad de la vacunación sistemática frente a la varicela a los niños de 15 meses de edad en Castilla y León. Métodos: Se ha planteado una evaluación económica de coste-beneficio a través de un árbol de decisión. Se estudia una cohorte ficticia de 100.000 niños castellano-leoneses que en el año 2004 cumplieran 15 meses, a los que se les administraría junto a la vacuna triple vírica la de la varicela. El estudio se plantea desde la perspectiva social. El horizonte temporal elegido ha sido hasta que la cohorte de estudio cumpliera 15 años, aplicando una tasa de descuento del 3%. Para valorar la incertidumbre de algunas variables se ha desarrollado un análisis de sensibilidad. Resultados: El coste-beneficio de la introducción de la vacuna en el calendario de vacunación infantil se cifra en 1,23. Conclusiones: Desde la perspectiva social la estrategia de vacunación frente a la varicela, junto a la triple vírica se muestra rentable. La rentabilidad se ve modificada tanto si se introduce una segunda dosis de vacuna como si se analizan sólo los costes directos sanitarios (AU)</dc:description>
<dc:source>Rev Esp Salud Publica;82(1): 101-109, ene.-feb. 2008. tab, ilus</dc:source>
<dc:identifier>ibc-126542</dc:identifier>
<dc:title xml:lang="es">Impacto social y económico de la vacunación frente a la varicela a los 15 meses de edad en Castilla y León en 2004</dc:title>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d28621</dc:subject>
<dc:subject>^d50095</dc:subject>
<dc:subject>^d2694</dc:subject>
<dc:subject>^d28485^s22018</dc:subject>
<dc:subject>^d29592^s22018</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d2689^s22054</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d2689^s22038</dc:subject>
<dc:subject>^d55050^s22045</dc:subject>
<dc:subject>^d29592^s22083</dc:subject>
<dc:subject>^d30313^s22045</dc:subject>
<dc:subject>^d22226</dc:subject>
<dc:subject>^d35160</dc:subject>
<dc:subject>^d29592^s22048</dc:subject>
<dc:subject>^d29592^s22045</dc:subject>
<dc:subject>^d29592^s22066</dc:subject>
<dc:subject>^d30313^s22083</dc:subject>
<dc:subject>^d28455^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>200802</dc:date>
</metadata>
</record>
</ibecs-document>
